The purpose of the Physician Scientist Training Program in Cancer Medicine is to enhance research training opportunities at the University of Wisconsin for physician scientists in the field of cancer medicine. During the past decade, the number of physicians entering academic medicine has decline, partly because of a limited number of institutions committed to the training of physician investigators. As a cancer center with a strong record of training high quality physician investigators and with particularly successful interactions between its laboratory and clinical programs, the University of Wisconsin Comprehensive Cancer Center is an excellent site for a formal research training program in cancer medicine. Participants in this program receive at least two years of investigative training in one of the established research programs of the UWCCC, such as radiobiology, drug development, biological response modifiers/immunology, genitourinary tract cancers, breast cancer, cell adhesion and signaling, carcinogenesis in in vitro human model systems, and cancer prevention. Trainees work closely with a faculty mentor on a specific project in one of the above areas. Projects are presented to the Physician Scientist Training Grant Committee by the trainee both orally and in written NIH grant format with progress reports presented to this Committee every six months. Trainees are also required to take the basic clinical trials biostatistics course offered by the Department of Biostatistics and are expected to take at least one other relevant course from the numerous graduate level courses offered on the UW campus. Applicants are drawn from the UW training programs in Medical Oncology, Radiation Therapy, Pediatric Oncology, Hematology and Internal Medicine. Candidates from other training program such as Urology, Surgical Oncology, Ophthalmology, Gastroenterology, etc. are considered if the applicant commits himself to focusing on a cancer related project and wishes to pursue a career in cancer medicine. Trainees are chosen based on the depth and quality of the applicant's research proposal. Five traineeships are awarded each year. Since the inception of this program in 1988, 21 trainees have completed their training. Fourteen of these trainees have assumed positions in academic medicine on the faculties of university cancer centers. Three additional trainees are negotiating with institutions for academic positions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009614-12
Application #
6172599
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
1988-08-01
Project End
2004-05-31
Budget Start
2000-06-01
Budget End
2001-05-31
Support Year
12
Fiscal Year
2000
Total Cost
$299,467
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Shahzad, Mian M K; Felder, Mildred; Ludwig, Kai et al. (2018) Trans10,cis12 conjugated linoleic acid inhibits proliferation and migration of ovarian cancer cells by inducing ER stress, autophagy, and modulation of Src. PLoS One 13:e0189524
Rampurwala, Murtuza; Wisinski, Kari B; Burkard, Mark E et al. (2017) Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer. Invest New Drugs 35:87-94
Wisinski, Kari B; Tevaarwerk, Amye J; Burkard, Mark E et al. (2016) Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast Cancer. Clin Cancer Res 22:2659-67
Hanson, Summer E; Kleinbeck, Kyle R; Cantu, David et al. (2016) Local delivery of allogeneic bone marrow and adipose tissue-derived mesenchymal stromal cells for cutaneous wound healing in a porcine model. J Tissue Eng Regen Med 10:E90-E100
Elsaid, M Y; Capitini, C M; Diamond, C A et al. (2016) Successful matched unrelated donor stem cell transplant in Hemoglobin Bart's disease. Bone Marrow Transplant 51:1522-1523
Hadac, Jamie N; Miller, Devon D; Grimes, Ian C et al. (2016) Heterochromatin Protein 1 Binding Protein 3 Expression as a Candidate Marker of Intrinsic 5-Fluorouracil Resistance. Anticancer Res 36:845-52
Graul-Conroy, Amanda; Hicks, Emily J; Fahl, William E (2016) Equivalent chemotherapy efficacy against leukemia in mice treated with topical vasoconstrictors to prevent cancer therapy side effects. Int J Cancer 138:3011-9
Rampurwala, Murtuza; Wisinski, Kari B; O'Regan, Ruth (2016) Role of the androgen receptor in triple-negative breast cancer. Clin Adv Hematol Oncol 14:186-93
Schneider, David F; Elfenbein, Dawn; Lloyd, Ricardo V et al. (2015) Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer. Ann Surg Oncol 22:158-63
Blute Jr, Michael L; Rushmer, Timothy J; Shi, Fangfang et al. (2015) Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer. J Urol 194:1214-9

Showing the most recent 10 out of 126 publications